Girolline, a 2-aminoimidazole derivative, was originally isolated as an antitumor compound from the marine sponge Peudaxinyssa cantharella collected in New Caledonia. 7) This compound exhibits significant cytotoxicity in vitro against several tumor cell lines and in vivo against murine grafted tumors, including P388 and L1210 leukemias, and solid tumors. 8) Although its structure suggests it has alkylating activity toward nucleic acids, biochemical study revealed that girolline is not an alkylating agent but is a protein synthesis inhibitor. 8) Further study suggested that girolline inhibits the termination step of protein synthesis. 9) Since toxicological study using dogs and mice suggested that girolline has little toxic effect, a phase I clinical study has been conducted. However, it was found that girolline had severe side effects in patients but no apparent antitumor activity. 10) Recently, we isolated girolline from another species of the marine sponge Axinella brevistyla collected in western Japan. We found that cells treated with girolline exhibited G2/M cell cycle arrest. An immunochemical study showed that girolline induced the accumulation of polyubiquitinated p53 but not that of other polyubiquitinated cellular proteins. On the other hand, girolline did not inhibit activity of the proteasome in vitro. Thus, the results suggest that girolline affects the step of recruitment of polyubiquitinated p53 to the proteasome.
MATERIALS AND METHODS

Materials
Girolline was isolated from the marine sponge Axinella brevistyla as previously reported.
11) Lepromycin B was a gift from Dr. M. Yoshida of RIKEN, Wako, Japan.
Cell Culture FL, HeLa and A549 cells were cultured in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum, penicillin (100 units/ml), and streptomycin (100 mg/ml) under a humidified atmosphere of 5% CO 2 at 37°C.
Flow Cytometric Analysis Cells were harvested by trypsin digestion, washed with cold phosphate-buffered saline (PBS), and fixed with ice-cold 70% ethanol. The fixed cells were collected by brief centrifugation and treated with PBS containing 500 mg/ml RNase A (Sigma) at 37°C for 20 min and then with 10 mg/ml propidium iodide (Wako Pure Chemicals) at room temperature for 15 min. Samples were then subjected to flow cytometric analysis by using a FACScalibur (Becton-Dickinson Immunocytometer Systems).
Preparation of Cell Extracts and Immunoprecipitation
The cells were disrupted with ice-cold buffer A consisting of 20 mM Tris-HCl, pH 7.5, 5 mM EDTA, 150 mM NaCl, 1% Nonidet P-40, 5 mM N-ethylmaleimide, 10 mM MG132 (Peptide Institute), and a proteasome inhibitor cocktail (Roche). After removing cell debris by centrifugation, the resulting supernatant was used as the cell extract. To immuoprecipitate p53, anti-p53 antibody-immobilized agarose beads (Santa Cruz) were added to the cell extract, and the mixture was stirred at 4°C for 2 h and centrifuged at 15000 rpm for 1 min. After the precipitated beads had been extensively washed with buffer A, the materials bound to the beads were subjected to SDS-PAGE and then to Western blotting as described below.
Gel Electrophoresis and Western Blotting SDS-PAGE was carried out in a slab gel containing 12% polyacrylamide. After SDS-PAGE and blotting to the membranes, blocking Girolline, an antitumor compound isolated from a sponge, has been reported to inhibit the termination step of protein synthesis in vivo. In this study, we found that girolline induced G2/M cell cycle arrest in several tumor cell lines. Immunochemical analysis revealed that polyubiquitinated p53 was accumulated in girolline-treated cells, while other polyubiquitinated cellular proteins were not accumulated, indicating that the effect of girolline is specific for p53. On the other hand, girolline did not inhibit proteasome activity in vitro, and accumulation of polyubiquitinated p53 was scarcely detected in the presence of leptomycin B, an inhibitor of nuclear export. Based on the above findings, we propose that girolline affects the step of recruitment of polyubiquitinated p53 to the proteasome.
with 5% skim milk in PBS containing 0.1% Tween 20 and immunoblotting were carried out. For immunochemical detection of p53 and ubiquitin, a mouse monoclonal antibody against human p53 (Santa Cruz) and a rabbit polyclonal antibody against bovine ubiquitin (DAKO), respectively, were used as primary antibodies and peroxidase-conjugated antimouse IgG or anti-rabbit IgG (Amersham) was used as a secondary antibody. For detection of polyubiquitin chains, FK1 antibody, which specifically recognizes polyubiquitin chains, 12) and biotin-conjugated anti-mouse IgM (Amersham) were used as the first and second antibodies, respectively. Detection was performed using an enhanced chemiluminescence system (Amersham), and bands were visualized with X-ray film.
Preparation of Proteasome-Enriched Fraction FL cells were centrifuged at 1000 rpm for 5 min, and the resultant packed cells were suspended in ice-cold buffer B consisting of 20 mM HEPES, pH 7.5, 5 mM KCl, 1.5 mM MgCl 2 , 1 mM dithiothreitol, 2 mM ATP, and 10% glycerol and were then disrupted by a Teflon homogenizer at 4°C for 5 min. The cell lysate was immediately centrifuged at 10000 rpm for 5 min, and the resultant supernatant was further centrifuged at 100000ϫg for 5 h. The precipitates thus obtained were suspended in buffer B and used as a proteasome-enriched preparation.
Assay for Proteasome Activity The fluorogenic substrate Suc-Leu-Leu-Val-Tyr-MCA (Peptide Institute) was used as a substrate for chymotrypsin-like activity of the proteasome. The ATP-activated activity of the proteasome was measured at 37°C for 30 min using the above proteasomeenriched preparation in a reaction mixture (1 ml) that contained 50 mM Tris-HCl, pH 7.8, 1 mM dithiothreitol, 10 mM MgCl 2 , 2 mM ATP, 0.05 mM substrate, and an enzyme solution (5 ml), and the reaction was stopped by adding 1 ml of 10% SDS. The fluorescence intensity derived from 7-amino-4-methylcoumarin (excitation, 380 nm; emission, 460 nm) was measured using a Shimadzu spectrofluorophotometer RF-5000.
RESULTS AND DISCUSSION
Girolline Induces G2/M Cell Cycle Arrest Girolline has been reported to inhibit protein synthesis. 8, 9) Since we also isolated girolline from another species of the marine sponge, we first carried out an experiment to determine whether girolline affects the cell cycles of several tumor cell lines. FL, HeLa, and A549 cells were cultured in the presence of 50 mM girolline for 24 h, washed with PBS, fixed, and stained with propidium iodide. The stained cells were then subjected to flow cytometric analysis to examine the cell cycle profile. As shown in Fig. 1 , girolline was found to induce G2/M cell cycle arrest in FL cells. Girolline-induced G2/M arrest was also observed in HeLa and A549 cells, though to a lesser extent (data not shown).
Polyubiquitinated p53 Accumulates in GirollineTreated Cells The tumor suppressor p53 has been reported to be involved in G2 cell cycle arrest as well as in G1 arrest. 5, 6, 13) Since we found that girolline induced G2/M cell cycle arrest, we next carried out an experiment to determine the relationship between girolline and p53. FL cells were cultured in the presence of 50 mM girolline for 24 h, and the cell extract was prepared and subjected to SDS-PAGE followed by Western blotting with anti-p53 antibody. Several bands with higher molecular masses than that of the original p53 were detected (data not shown). To characterize the highmolecular-mass bands of p53, the cell extract was subjected to immunoprecipitation using anti-p53 antibody-immobilized agarose, and the immunoprecipitates thus formed were then subjected to Western blotting with anti-p53 and anti-ubiquitin antibodies (Fig. 2) . It was found that, among the bands recognized by anti-p53 antibody, two bands with 70 kDa and 58 kDa also immunoreacted with anti-ubiquitin antibody, indicating that the immunoreactive bands are derived from polyubiquitinated p53. In addition, it should be noted that the bands recognized by both antibodies became stronger as the concentration of girolline used was increased. These results indicate that girolline induces accumulation of polyubiquitinated p53 in a concentration-dependent manner. The absence of two anti-p53 immunoreactive bands with 70 and 58 kDa in control may be partly due to the difference in sensitivity of antibodies used.
Girolline Is Unable to Inhibit the Activity of the Proteasome and Nuclear Export of p53 To determine whether the accumulation of polyubiquitinated p53, induced by girolline treatment, was due to its inhibition of the activity of the proteasome, we assayed chymotrypsin-like activity of the proteasome toward Suc-Leu-Leu-Val-Tyr-MCA in the presence of girolline. It was found that girolline did not inhibit the proteasome activity even at the concentration of 200 mM, while MG132 at 10 mM completely inhibited the proteasome activity. In contrast, MG132 induced accumulation of polyubiquitinated p53 as girolline did (see Fig. 3 ).
It has been reported that some proteins such as p27, a cyclin-dependent kinase inhibitor, are polyubiquitinated/degraded inside the nucleus, or, alternatively, are exported to 700 Vol. 27, No. 5 
Fig. 2. Girolline Induces Accumulation of Polyubiquitinated p53
FL cells were cultured in the presence of girolline for 24 h, and the cell extract was prepared and subjected to immunoprecipitation (IP) using anti-p53 antibody-immobilized agarose. The immunoprecipitates thus formed were then subjected to Western blotting with anti-p53 (left panel) and anti-ubiquitin (anti-Ub) (right panel) antibodies. IB, immunoblotting. the cytoplasm and are then polyubiquitinated/degraded. 14, 15) To examine the possibility that girolline affects the export of polyubiquitinated p53 from the nucleus, we compared the effects of girolline and leptomycin B, an inhibitor of nuclear export, on accumulation of polyubiquitinated p53 (Fig. 3) . Leptomycin B has been reported to completely inhibit MDM2-and E6-AP-dependent proteasomal degradation of p53. 16) In contrast to the effect of girolline, leptomycin B did not induce accumulation of polyubiquitinated p53. These results strongly suggest that girolline does not inhibit the nuclear export of polyubiquitinated p53.
The Effect of Girolline is Specific for p53 We next carried out an experiment to determine whether treatment with girolline results in accumulation of polyubiquitinated proteins other than p53. Cell extracts prepared from FL cells that had been pretreated with girolline and MG132 (a positive control) were subjected to SDS-PAGE and then to Western blotting with FK1 antibody, which specifically recognizes polyubiquitin chains (Fig. 4) . 12) MG132, a proteasome inhibitor, induced accumulation of polyubiquitinated cellular proteins. In contrast, treatment with girolline induced little accumulation of polyubiquitinated cellular proteins. These results strongly suggest that the effect of girolline is specific for p53 and that this compound inhibits the degradation of polyubiquitinated p53 but not that of other polyubiquitinated cellular proteins.
A Possible Target of Girolline Girolline has been reported to inhibit protein synthesis. 8) In contrast, in our study, treatment with cycloheximide, a protein synthesis inhibitor, induced little accumulation of polyubiquitinated p53 (data not shown). Since polyubiquitinated proteins are targeted to the proteasome and degraded, all of the above results suggest that girolline inhibits recruitment of polyubiquitinated p53 to the proteasome. Rad23 and Dsk2, ubiquitin-like proteins that have affinities toward polyubiquitinated proteins and also are capable of binding to the proteasome, have been reported to function in the recruitment of polyubiquitinated proteins to the proteasome. 17) It is quite possible that the target of girolline is such a factor functioning in the recruitment of polyubiquitinated p53 to the proteasome. Since girolline failed to induce accumulation of other polyubiquitinated cellular proteins, the candidate factor seems to be specific for p53. Although the target of girolline has not yet been identified, it can be concluded that girolline is a novel-type inhibitor against the ubiquitin-dependent proteplytic pathway.
It is well known that p53-dependent G1 arrest of the cell cycle is an important component of the cellular response to stress, but the mechanism of p53-dependent G2 arrest has not yet been elucidated. 5, 6, 13) Girolline induces mainly G2/M arrest in FL (wild type p53), HeLa (defective p53), and A549 (wild type p53) cells and also induces the accumulation of polyubiquitinated p53 at least in FL cells. Further study is required to determine whether accumulation of polyubiquitinated p53 causes G2/M arrest. Cell extracts were prepared from FL cells cultured in the presences of 50 mM girolline, 2 mM MG132, and 50 ng/ml leptomycin B for 24 h and were then subjected to immunoprecipitation (IP) using anti-p53 antibody-immobilized agarose. The immunoprecipitates thus formed were then subjected to Western blotting with anti-p53 antibody. IB, immunoblotting.
Fig. 4. Girolline Fails to Induce Accumulation of Polyubiquitinated Cellular Proteins
Cell extracts prepared from FL cells cultured in the presence of 50 mM girolline and 2 mM MG132 were subjected to SDS-PAGE and then to Western blotting with FK1 antibody, which specifically recognizes polyubiquitin chains (anti-polyUb). IB, immunoblotting.
